ACADIA Pharma Floats New Stock Issue

ACADIA Pharmaceuticals (NASDAQ: ACAD  ) will soon be almost $100 million richer, if a fresh stock issue goes as planned. The company is floating 8 million shares of its common stock in an underwritten public flotation, at a price of $12.50 apiece. Additionally, the firm's underwriters have been granted a 30-day purchase option for up to an additional 1.2 million shares to cover overallotments, if any.

ACADIA said it plans to use the proceeds of the issue to finance current and future clinical trials, the development and marketing of its pimavanserin treatment as well as other products, and for "general corporate purposes."

Leucadia's Jefferies and Cowen Group's Cowen and Company are the joint book-running managers of the issue. ACADIA expects the offering to close on or about May 20.

Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

DocumentId: 2433806, ~/Articles/ArticleHandler.aspx, 4/17/2014 2:57:08 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 16,435.43 10.58 0.06%
S&P 500 1,867.47 5.16 0.28%
NASD 4,106.39 20.16 0.49%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

4/17/2014 2:34 PM
ACAD $19.34 Up +0.06 +0.31%
ACADIA Pharmaceuti… CAPS Rating: **